These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27183901)

  • 21. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barriers to seeking help among children with attention deficit hyperactivity disorder in Taiwan.
    Tzang RF; Chang YC; Chen CC
    Asia Pac Psychiatry; 2014 Dec; 6(4):373-8. PubMed ID: 23857893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of the consistency of atomoxetine treatment effects in pediatric patients with attention-deficit/hyperactivity disorder from 15 clinical trials across four geographic regions.
    Tanaka Y; Rohde LA; Jin L; Feldman PD; Upadhyaya HP
    J Child Adolesc Psychopharmacol; 2013 May; 23(4):262-70. PubMed ID: 23683141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry.
    Asherson P; Chen W; Craddock B; Taylor E
    Br J Psychiatry; 2007 Jan; 190():4-5. PubMed ID: 17197649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysis.
    Adler LA; Wilens T; Zhang S; Dittmann RW; D'Souza DN; Schuh L; Durell TM
    Clin Ther; 2012 Feb; 34(2):363-73. PubMed ID: 22285724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of a telehealth service delivery model for treating attention-deficit/hyperactivity disorder: a community-based randomized controlled trial.
    Myers K; Vander Stoep A; Zhou C; McCarty CA; Katon W
    J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):263-74. PubMed ID: 25791143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Attention-deficit/hyperactivity disorder in childhood/adolescence and impairments associated with daily life: French data from the European Lifetime Impairment Survey].
    Caci H; Paillé S
    Arch Pediatr; 2014 Dec; 21(12):1283-92. PubMed ID: 25300717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder.
    Walker DJ; Mason O; Clemow DB; Day KA
    Postgrad Med; 2015; 127(7):686-701. PubMed ID: 26343377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lost in transition: A review of the unmet need of patients with attention deficit/hyperactivity disorder transitioning to adulthood.
    Treuer T; Chan KLP; Kim BN; Kunjithapatham G; Wynchank D; Semerci B; Montgomery W; Novick D; Dueñas H
    Asia Pac Psychiatry; 2017 Jun; 9(2):. PubMed ID: 27552649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A practical guide to recognition and diagnosis of ADHD in adults in the primary care setting.
    Culpepper L; Mattingly G
    Postgrad Med; 2008 Sep; 120(3):16-26. PubMed ID: 18824822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attention-deficit hyperactivity disorder.
    Calis KA; Grothe DR; Elia J
    Clin Pharm; 1990 Aug; 9(8):632-42. PubMed ID: 1974836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pearls, perils, and pitfalls in the assessment and treatment of attention-deficit/hyperactivity disorder in adolescents.
    Obioha O; Adesman A
    Curr Opin Pediatr; 2014 Feb; 26(1):119-29. PubMed ID: 24370490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical recognition and management of adult attention deficit hyperactivity disorder.
    Craig C
    Nurse Pract; 1996 Nov; 21(11):101-6, 108. PubMed ID: 8933539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and neurobiological factors in the management of treatment refractory attention-deficit hyperactivity disorder.
    Shim SH; Yoon HJ; Bak J; Hahn SW; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():237-44. PubMed ID: 27103462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data.
    Biederman J; Spencer TJ; Newcorn JH; Gao H; Milton DR; Feldman PD; Witte MM
    Psychopharmacology (Berl); 2007 Jan; 190(1):31-41. PubMed ID: 17093981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updated European Consensus Statement on diagnosis and treatment of adult ADHD.
    Kooij JJS; Bijlenga D; Salerno L; Jaeschke R; Bitter I; Balázs J; Thome J; Dom G; Kasper S; Nunes Filipe C; Stes S; Mohr P; Leppämäki S; Casas M; Bobes J; Mccarthy JM; Richarte V; Kjems Philipsen A; Pehlivanidis A; Niemela A; Styr B; Semerci B; Bolea-Alamanac B; Edvinsson D; Baeyens D; Wynchank D; Sobanski E; Philipsen A; McNicholas F; Caci H; Mihailescu I; Manor I; Dobrescu I; Saito T; Krause J; Fayyad J; Ramos-Quiroga JA; Foeken K; Rad F; Adamou M; Ohlmeier M; Fitzgerald M; Gill M; Lensing M; Motavalli Mukaddes N; Brudkiewicz P; Gustafsson P; Tani P; Oswald P; Carpentier PJ; De Rossi P; Delorme R; Markovska Simoska S; Pallanti S; Young S; Bejerot S; Lehtonen T; Kustow J; Müller-Sedgwick U; Hirvikoski T; Pironti V; Ginsberg Y; Félegyházy Z; Garcia-Portilla MP; Asherson P
    Eur Psychiatry; 2019 Feb; 56():14-34. PubMed ID: 30453134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Attention deficit hyperactivity disorder in adults: a clinical and therapeutic characterization].
    Ramos-Quiroga JA; Bosch-Munsó R; Castells-Cervelló X; Nogueira-Morais M; García-Gimenez E; Casas-Brugué M
    Rev Neurol; 2006 May 16-31; 42(10):600-6. PubMed ID: 16703528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.